During the past decade, Childhood Hematology/Oncology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Childhood Hematology/Oncology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator and "Children's Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Childhood Hematology/Oncology Associates" are "Brain and Central Nervous System Tumors" (2 trials), "Kidney Cancer" (2 trials), "Leukemia" (2 trials), "Sarcoma" (2 trials) and "Brain Tumor" (1 trials). Many other conditions were trialed in "Childhood Hematology/Oncology Associates" in a lesser frequency.

Most popular intervention types in "Childhood Hematology/Oncology Associates" are "Drug" (9 trials), "Biological" (4 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "filgrastim" (4 trials), "cyclophosphamide" (3 trials), "etoposide" (3 trials), "carboplatin" (2 trials) and "conventional surgery" (2 trials). Other intervention names were less common.

The vast majority of trials in "Childhood Hematology/Oncology Associates" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Childhood Hematology/Oncology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Childhood Hematology/Oncology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Childhood Hematology/Oncology Associates, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".